DCPH

Deciphera Pharmaceuticals, Inc.

No insider bought or sold Deciphera Pharmaceuticals, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow DCPH

DCPH over the last year

Prices for DCPH aren't in yet.

DCPH after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

94 insider filings since 2017, newest first

DCPHSell

Matthew L Sherman · EVP and Chief Medical Officer

$41K−2.0%Feb 20

DCPHSell

Thomas Patrick Kelly · CFO

$47K−4.0%Feb 20

DCPHSell

Jama Pitman · SVP and Chief Development Officer

$35K−3.0%Feb 20

DCPHSell

Daniel C. Martin · Chief Commercial Officer

$35K−4.0%Feb 20

DCPHSell

Matthew L Sherman · EVP and Chief Medical Officer

$35K−3.0%Jan 18

DCPHSell

Thomas Patrick Kelly · CFO

$35K−4.0%Jan 18

DCPHSell

Steven L. Hoerter · President and CEO

$471K−30.0%Dec 14

DCPHSell

Thomas Patrick Kelly · CFO

$43K−4.0%Dec 14

DCPHSell

Jama Pitman · Insider

$26K−3.0%Dec 14

DCPHSell

Daniel C. Martin · Chief Commercial Officer

$27K−3.0%Dec 14

DCPHSell

Matthew L Sherman · EVP and Chief Medical Officer

$43K−3.0%Dec 14

DCPHSell

Daniel C. Martin · Chief Commercial Officer

$224K−28.0%Dec 1

DCPHSell

Steven L. Hoerter · President and CEO

$259K−35.0%Oct 31

DCPHSell

Matthew L Sherman · EVP and Chief Medical Officer

$28K−3.0%Oct 31

DCPHSell

Thomas Patrick Kelly · CFO

$28K−4.0%Oct 31

DCPHSell

Matthew L Sherman · EVP and Chief Medical Officer

$37K−3.0%Oct 4

DCPHBuy

Franklin Stuart Friedman · Director

$139KJun 12

DCPHBuy

Dennis Leo Walsh · Director

$152KMay 12

DCPHSell

Steven L. Hoerter · President and CEO

$117K−100.0%Mar 23

DCPHSell

Steven L. Hoerter · President and CEO

$481K−80.0%Feb 16

DCPHBuy

Brightstar Associates LLC · 10% owner

$30.0M+9.0%Jan 24

DCPHSell

Daniel Lee Flynn · Chief Scientific Officer

$51K−1.0%Jan 19

DCPHSell

Jama Pitman · Insider

$34K−4.0%Jan 19

DCPHSell

Matthew L Sherman · EVP and Chief Medical Officer

$51K−3.0%Jan 19

DCPHSell

Daniel C. Martin · Chief Commercial Officer

$34K−3.0%Jan 19

DCPHSell

Thomas Patrick Kelly · CFO

$51K−5.0%Jan 19

DCPHSell

Matthew L Sherman · EVP and Chief Medical Officer

$48K−3.0%Oct 5

DCPHBuy

Brightstar Associates LLC · 10% owner

$14.8M+9.0%Apr 29

DCPHSell

Matthew L Sherman · EVP and Chief Medical Officer

$88K−5.0%Oct 6

DCPHSell

Michael Douglas Taylor · Director

$369K−100.0%May 5

DCPHSell

James Arthur Bristol · Director

$323K−100.0%Apr 21

DCPHSell

James Arthur Bristol · Director

$644K−100.0%Apr 14

DCPHSell

Michael Douglas Taylor · Director

$365K−100.0%Apr 6

DCPHSell

Michael Douglas Taylor · Director

$352K−100.0%Mar 3

DCPHSell

Thomas Patrick Kelly · CFO

$26K−3.0%Feb 18

DCPHSell

Michael Douglas Taylor · Director

$362K−100.0%Feb 3

DCPHSell

James Arthur Bristol · Director

$352K−100.0%Jan 20

DCPHSell

Michael Douglas Taylor · Director

$1.1M−100.0%Jan 6

DCPHSell

Michael Douglas Taylor · Director

$1.2M−100.0%Dec 3

DCPHSell

Michael Douglas Taylor · Director

$972K−100.0%Nov 6

DCPHSell

Michael Douglas Taylor · Director

$1.3M−100.0%Nov 4

DCPHSell

James Arthur Bristol · Director

$1.3M−100.0%Oct 13

DCPHSell

Michael Douglas Taylor · Director

$6.5M−100.0%Oct 5

DCPHSell

Thomas Patrick Kelly · CFO

$150K−30.0%Sep 16

DCPHSell

Thomas Patrick Kelly · CFO

$416K−56.0%Sep 10

DCPHSell

James Arthur Bristol · Director

$1.3M−100.0%Jul 13

DCPHSell

Michael Douglas Taylor · Director

$7.2M−100.0%Jul 6

DCPHSell

Patricia L Allen · Director

$691K−100.0%Jun 5

DCPHSell

Thomas Patrick Kelly · CFO

$662K−63.0%May 13

DCPHSell

Michael Douglas Taylor · Director

$1.4M−100.0%Apr 30

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.